Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and Vaccines

Posted : Fri, 06 Nov 2009 01:59:25 GMT
Author : PRWeb
Category : Press Release
News Alerts by Email ( click here )
News | Home

Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC.

Horsham, PA (Vocus) November 5, 2009 -- Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC.

This conference will explore the essential components of RMP as they apply to medicinal products, therapeutic biologics, and vaccines with a focus on real and potential risks of products, which may be made available to patients and healthcare providers in different regions of the world. Sessions will include: “The 2nd DIA Conference on Harmonization of Risk Management Plans will bring together global regulators and industry representatives to lead hands-on exercises and didactic presentations and to participate in panel discussions,” explains Program Chair William W. Gregory, Director, Safety and Risk Management, Pfizer Inc. “They will discuss why RMPs are important to your organization from a global regulatory perspective, the pros and cons of a global vs. local approach to developing RMPs, how an harmonized RMP can promote efficient, evidence-based decision-making to support the best use of marketed products, and how to develop an harmonized approach to creating an RMP.”

Register for the 2nd DIA Conference on Harmonization of Risk Management Plans.

About the Drug Information Association (DIA): A non-profit, neutral, multidisciplinary, global, member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit www.diahome.org or call 215-442-6100.

Contact: Joe Krasowski DIA +1-215-293-5812

###

Share/Save/Bookmark

Article : DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and Vaccines
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Forest City Statement on New York State Court of Appeals Eminent Domain Ruling for Atlantic Yards Project
CLEVELAND, Nov. 24 -- Forest City Enterprises, Inc. (NYSE: FCEA and FCEB) issued the following statement from President and Chief Executive Officer Charles A. Ratner in response to today's favorable New York State Court of Appeals ruling in a lawsuit relate...

RedEye (Universal Remote System for iPhone & iPod touch): Now Most Popular Remote Control Fan Page on Facebook
WALTHAM, MA -- 11/24/09 -- ThinkFlood (http://thinkflood.com/), maker of the RedEye personal remote control for iPhone and iPod touch, today announced that two months after launching its fan page (

Biospace Med Expands European Market Penetration with ‘EOS’, Which Cuts Radiation up to 90% vs. Conventional X-Rays
CAMBRIDGE, Mass. & PARIS - Biospace med announced today that it continues to penetrate the European market with its CE Marked ‘EOS’ x-ray imager—the world’s first ultra-low-dose x-ray technology—recently adding two new regions of

Charter Financial Declares Quarterly Cash Dividend
WEST POINT, Ga., Nov. 24 -- Charter Financial Corporation (OTC Bulletin Board: CHFN) today announced that its board of directors has declared a quarterly cash dividend of 25 cents per share. The dividend is payable on December 30, 2009, to stockholders of record D...

Volkswagen Jetta, Jetta SportWagen, Passat, CC and Tiguan Outrank the Competition in Strategic Vision's 2009 Total Value Index(TM) (TVI)
HERNDON, Va., Nov. 24 /PRNewswire/ -- Volkswagen of America, Inc. announced today that five of its vehicles have received top ratings from buyers in Strategic Vision's 2009 Total Value Index(TM) (TVI). Volkswagen's Jetta and Passat tied for first place in the medium car category, th...

SBA Offers Disaster Assistance to North Carolina Businesses Economically Affected by the Landslide
WASHINGTON - Low-interest disaster loans are available in North Carolina to small businesses, small agricultural cooperatives and most private non-profit organizations of all sizes affected by a landslide on Interstate 40 that occurred on October 25, 2009 and continuing.

Tri Tax Launches Turn-Key Business Opportunity That Makes Franchise Ownership Easier Than Ever
'Business in a Box' gives franchisees all the tools they need to be successful from the start SAN PEDRO, Calif., Nov. 24 /PRNewswire-USNewswire/ -- If you've always dreamed of owning your own business but feared the risks involved, Tri Tax offers a revolutionary...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.